Arvinas, Inc. (ARVN) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Arvinas, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:04.720 Thank you for standing by. At this time, I would like to welcome everyone to our VINA's 00:00:04.720 -- 00:00:09.880 second quarter 2025 earnings call. All lines have been placed on mute to prevent 00:00:09.880 -- 00:00:14.820 any background noise. After the speakers' remarks, there will be a question and answer 00:00:14.820 -- 00:00:19.540 session. If you would like to ask a question during this time, simply press star followed 00:00:19.540 -- 00:00:22.460 by the number one on your telephone keypad. 00:00:22.460 -- 00:00:27.940 Thank you. I would now like to turn the conference over to Jeff Boyle, our VINA's 00:00:27.940 -- 00:00:33.180 Vice President of Investor Relations. Please go ahead. 00:00:34.120 -- 00:00:36.740 Good morning, everyone, and thank you for joining us. 00:00:36.740 -- 00:00:41.220 Earlier today, we issued a press release with our second quarter 2025 financial results, 00:00:41.220 -- 00:00:46.160 which is available in the investor and media section of our website at ourvinas.com. 00:00:46.160 -- 00:00:50.640 Joining the call today are John Hewson, our VINA's Chief Executive Officer, President, 00:00:50.640 -- 00:00:55.660 and Chairperson, Noah Berkowitz, our Chief Medical Officer, Angela Kakey, our 00:00:55.660 -- 00:01:00.620 Chief Scientific Officer, and Andrew Stake, our Chief Financial Officer. 00:01:00.620 -- 00:01:04.640 Before we begin the call, I'll remind you that today's discussion contains forward-looking 00:01:04.640 -- 00:01:08.280 statements that involve risks, uncertainties, and assumptions. 00:01:08.280 -- 00:01:12.200 These risks and uncertainties are outlined in today's press release and in the company's 00:01:12.200 -- 00:01:16.060 recent filing with the Securities and Exchange Commission, wh...